• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动态对比增强磁共振成像纹理分析预测人表皮生长因子受体2(HER2)2+状态的潜在应用

The Potential Use of DCE-MRI Texture Analysis to Predict HER2 2+ Status.

作者信息

Jiang Zejun, Song Lirong, Lu Hecheng, Yin Jiandong

机构信息

Shengjing Hospital of China Medical University, Shenyang, China.

School of Sino-Dutch Biomedical and Information Engineering, Northeastern University, Shenyang, China.

出版信息

Front Oncol. 2019 Apr 12;9:242. doi: 10.3389/fonc.2019.00242. eCollection 2019.

DOI:10.3389/fonc.2019.00242
PMID:31032222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6473324/
Abstract

To evaluate the ability of texture analysis of breast dynamic contrast enhancement-magnetic resonance (DCE-MR) images in differentiating human epidermal growth factor receptor 2 (HER2) 2+ status of breast tumors. A total of 73 cases were retrospectively selected. HER2 2+ status was confirmed by fluorescence hybridization. For each case, 279 textural features were derived. A student's -test or Mann-Whitney U test was used to select features with statistically significant differences between HER2 2+ positive and negative groups. A principal component analysis was applied to eliminate feature correlation. Three machine learning classifiers, logistic regression (LR), quadratic discriminant analysis (QDA), and a support vector machine (SVM), were trained and tested using a leave-one-out cross-validation method. The area under a receiver operating characteristic curve (AUC) was measured to assess the classifier's performance. The AUCs for the different classifiers were satisfactory, ranging from 0.808 to 0.865. The classification methods derived with LR and SVM demonstrated similarly high performances, and the accuracy levels were 81.06 and 81.18%, respectively. The AUC for the classifier derived with SVM was the highest (0.865), and a marked specificity (88.90%) was presented. For the classifier with LR, the AUC was 0.851, and the corresponding sensitivity (94.44%) was the highest. The texture analysis for breast DCE-MRI proposed in this study demonstrated potential utility in HER2 2+ status discrimination.

摘要

评估乳腺动态对比增强磁共振(DCE-MR)图像纹理分析在鉴别乳腺肿瘤人表皮生长因子受体2(HER2)2+状态中的能力。回顾性选取73例病例。通过荧光杂交确认HER2 2+状态。对于每个病例,提取279个纹理特征。采用学生t检验或曼-惠特尼U检验选择HER2 2+阳性和阴性组之间具有统计学显著差异的特征。应用主成分分析消除特征相关性。使用留一法交叉验证方法训练和测试三种机器学习分类器,即逻辑回归(LR)、二次判别分析(QDA)和支持向量机(SVM)。测量受试者工作特征曲线(AUC)下的面积以评估分类器的性能。不同分类器的AUC令人满意,范围为0.808至0.865。由LR和SVM得出的分类方法表现出相似的高性能,准确率分别为81.06%和81.18%。由SVM得出的分类器的AUC最高(0.865),并呈现出显著的特异性(88.90%)。对于LR分类器,AUC为0.851,相应的灵敏度(94.44%)最高。本研究中提出的乳腺DCE-MRI纹理分析在HER2 2+状态鉴别中显示出潜在效用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ab/6473324/7eda1699f644/fonc-09-00242-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ab/6473324/cbe63d6d1440/fonc-09-00242-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ab/6473324/7eda1699f644/fonc-09-00242-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ab/6473324/cbe63d6d1440/fonc-09-00242-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ab/6473324/7eda1699f644/fonc-09-00242-g0004.jpg

相似文献

1
The Potential Use of DCE-MRI Texture Analysis to Predict HER2 2+ Status.动态对比增强磁共振成像纹理分析预测人表皮生长因子受体2(HER2)2+状态的潜在应用
Front Oncol. 2019 Apr 12;9:242. doi: 10.3389/fonc.2019.00242. eCollection 2019.
2
Preliminary study on discriminating HER2 2+ amplification status of breast cancers based on texture features semi-automatically derived from pre-, post-contrast, and subtraction images of DCE-MRI.基于 DCE-MRI 增强前后图像和减影图像的纹理特征半自动鉴别乳腺癌 HER2 2+扩增状态的初步研究。
PLoS One. 2020 Jun 17;15(6):e0234800. doi: 10.1371/journal.pone.0234800. eCollection 2020.
3
Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status.基于瘤内亚区域的乳腺动态对比增强磁共振成像纹理分析预测HER2 2+状态
Front Oncol. 2020 Apr 21;10:543. doi: 10.3389/fonc.2020.00543. eCollection 2020.
4
Texture Analysis Using Semiquantitative Kinetic Parameter Maps from DCE-MRI: Preoperative Prediction of HER2 Status in Breast Cancer.使用DCE-MRI的半定量动力学参数图进行纹理分析:乳腺癌中HER2状态的术前预测
Front Oncol. 2021 Jun 8;11:675160. doi: 10.3389/fonc.2021.675160. eCollection 2021.
5
Texture Analysis of DCE-MRI Intratumoral Subregions to Identify Benign and Malignant Breast Tumors.动态对比增强磁共振成像(DCE-MRI)瘤内亚区域的纹理分析用于鉴别乳腺良恶性肿瘤
Front Oncol. 2021 Jul 8;11:688182. doi: 10.3389/fonc.2021.688182. eCollection 2021.
6
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.基于乳腺动态对比增强磁共振成像的瘤内和瘤周影像组学对新辅助化疗病理完全缓解的治疗前预测
Breast Cancer Res. 2017 May 18;19(1):57. doi: 10.1186/s13058-017-0846-1.
7
Preliminary study on DCE-MRI radiomics analysis for differentiation of HER2-low and HER2-zero breast cancer.DCE-MRI 影像组学分析用于鉴别 HER2 低表达和 HER2 零表达乳腺癌的初步研究
Front Oncol. 2024 Aug 15;14:1385352. doi: 10.3389/fonc.2024.1385352. eCollection 2024.
8
Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.基于放射组学的动态对比增强磁共振成像与基于非单指数模型的扩散加权成像在预测乳腺癌预后生物标志物和分子亚型中的比较
J Magn Reson Imaging. 2023 Nov;58(5):1590-1602. doi: 10.1002/jmri.28611. Epub 2023 Jan 20.
9
Role of sureness in evaluating AI/CADx: Lesion-based repeatability of machine learning classification performance on breast MRI.Surety 在评估 AI/CADx 中的作用:基于病灶的机器学习分类性能在乳腺 MRI 上的重复性。
Med Phys. 2024 Mar;51(3):1812-1821. doi: 10.1002/mp.16673. Epub 2023 Aug 21.
10
Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.基于典型相关分析的特征融合方法整合动态对比增强磁共振成像和 T2 加权成像放射组学特征,以预测导管乳腺癌的组织学分级。
Phys Med Biol. 2019 Oct 23;64(21):215001. doi: 10.1088/1361-6560/ab3fd3.

引用本文的文献

1
Prediction of HER2 expression in breast cancer patients based on multi-parametric MRI intratumoral and peritumoral radiomics features combined with clinical and imaging indicators.基于多参数MRI肿瘤内和肿瘤周围影像组学特征联合临床及影像指标预测乳腺癌患者的HER2表达
Front Oncol. 2025 Jun 9;15:1531553. doi: 10.3389/fonc.2025.1531553. eCollection 2025.
2
Review of In Situ Hybridization (ISH) Stain Images Using Computational Techniques.使用计算技术对原位杂交(ISH)染色图像进行综述。
Diagnostics (Basel). 2024 Sep 21;14(18):2089. doi: 10.3390/diagnostics14182089.
3
Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review).

本文引用的文献

1
Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status.计算机辅助乳腺磁共振成像评估导管原位癌异质性分析:与组织学分级和受体状态的相关性。
J Magn Reson Imaging. 2017 Dec;46(6):1748-1759. doi: 10.1002/jmri.25712. Epub 2017 Apr 3.
2
Molecular Testing in Breast Cancer: A Guide to Current Practices.乳腺癌的分子检测:当前实践指南
Arch Pathol Lab Med. 2016 Aug;140(8):815-24. doi: 10.5858/arpa.2016-0051-RA.
3
Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
人工智能在卵巢癌诊断和治疗中的进展(综述)。
Oncol Rep. 2024 Mar;51(3). doi: 10.3892/or.2024.8705. Epub 2024 Jan 19.
4
Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results.基于超声放射组学和临床特征的机器学习模型,用于预测免疫组织化学结果不确定(2+)的乳腺癌患者的 HER2 状态。
Cancer Med. 2024 Feb;13(3):e6946. doi: 10.1002/cam4.6946. Epub 2024 Jan 17.
5
Discrimination between human epidermal growth factor receptor 2 (HER2)-low-expressing and HER2-overexpressing breast cancers: a comparative study of four MRI diffusion models.人表皮生长因子受体 2(HER2)低表达与过表达乳腺癌的鉴别:四种 MRI 扩散模型的比较研究。
Eur Radiol. 2024 Apr;34(4):2546-2559. doi: 10.1007/s00330-023-10198-x. Epub 2023 Sep 6.
6
The use of radiomics in magnetic resonance imaging for the pre-treatment characterisation of breast cancers: A scoping review.磁共振成像中放射组学在乳腺癌治疗前特征描述中的应用:范围综述。
J Med Radiat Sci. 2023 Dec;70(4):462-478. doi: 10.1002/jmrs.709. Epub 2023 Aug 3.
7
Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer.动态对比增强磁共振成像参数图和表观扩散系数图的影像组学预测乳腺癌Ki-67状态
Front Oncol. 2022 Nov 25;12:847880. doi: 10.3389/fonc.2022.847880. eCollection 2022.
8
Potential of the Non-Contrast-Enhanced Chest CT Radiomics to Distinguish Molecular Subtypes of Breast Cancer: A Retrospective Study.非增强胸部CT影像组学鉴别乳腺癌分子亚型的潜力:一项回顾性研究
Front Oncol. 2022 Mar 21;12:848726. doi: 10.3389/fonc.2022.848726. eCollection 2022.
9
Relationship between histogram metrics of pharmacokinetic parameters of DCE-MRI and histological phenotype in breast cancer.动态对比增强磁共振成像(DCE-MRI)药代动力学参数的直方图指标与乳腺癌组织学表型之间的关系
Transl Cancer Res. 2020 Jan;9(1):30-41. doi: 10.21037/tcr.2019.11.10.
10
MRI-Based Machine Learning in Differentiation Between Benign and Malignant Breast Lesions.基于磁共振成像的机器学习在乳腺良恶性病变鉴别中的应用
Front Oncol. 2021 Oct 18;11:552634. doi: 10.3389/fonc.2021.552634. eCollection 2021.
在动态对比增强磁共振成像(DCE-MRI)上对雌激素受体(ER)状态、人表皮生长因子受体2(HER2)状态和TN分子亚型评估进行乳腺肿瘤异质性的量化。
Magn Reson Imaging. 2016 Jul;34(6):809-819. doi: 10.1016/j.mri.2016.03.001. Epub 2016 Mar 8.
4
Texture analysis on MR images helps predicting non-response to NAC in breast cancer.磁共振成像的纹理分析有助于预测乳腺癌对新辅助化疗无反应。
BMC Cancer. 2015 Aug 5;15:574. doi: 10.1186/s12885-015-1563-8.
5
Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.乳腺癌亚型间肿瘤异质性:基于MRI的特征可预测基因组检测结果。
J Magn Reson Imaging. 2015 Nov;42(5):1398-406. doi: 10.1002/jmri.24890. Epub 2015 Apr 7.
6
Quantification of heterogeneity as a biomarker in tumor imaging: a systematic review.肿瘤成像中作为生物标志物的异质性定量:一项系统综述。
PLoS One. 2014 Oct 20;9(10):e110300. doi: 10.1371/journal.pone.0110300. eCollection 2014.
7
Correlation between magnetic resonance imaging grading and pathological grading in meningioma.脑膜瘤磁共振成像分级与病理分级的相关性
J Neurosurg. 2014 Nov;121(5):1201-8. doi: 10.3171/2014.7.JNS132359. Epub 2014 Aug 22.
8
DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker.肝细胞癌的动态对比增强磁共振成像——临床与治疗影像生物标志物
World J Gastroenterol. 2014 Mar 28;20(12):3125-34. doi: 10.3748/wjg.v20.i12.3125.
9
Tumour heterogeneity in the clinic.临床中的肿瘤异质性。
Nature. 2013 Sep 19;501(7467):355-64. doi: 10.1038/nature12627.
10
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.不同内在型乳腺癌亚型新辅助化疗后病理完全缓解对预后的定义和影响。
J Clin Oncol. 2012 May 20;30(15):1796-804. doi: 10.1200/JCO.2011.38.8595. Epub 2012 Apr 16.